93 results on '"Escrig, A."'
Search Results
2. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
3. Indication for a single postoperative instillation of chemotherapy in non-muscle-invasive bladder cancer: What factors should be considered?
4. External validation of SelectMDx (v1) in an opportunistic screening cohort in first TRUS-guided biopsy without MRI imaging
5. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review
6. External validation of SelectMDx (v1) in an opportunistic screening cohort in first TRUS-guided biopsy without MRI imaging
7. Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer
8. Predictors of transition to watchful waiting from active surveillance among men with low-risk prostate cancer in a Caucasian cohort
9. Zero PSA after RP: It is reasonable in selected N+ prostate cancer patients if a ePLND is performed
10. Established stress urinary incontinence after radical prostatectomy: A risk calculator based on the 24-hour pad weight test
11. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review
12. Suburethral male sling: Correlation between continence outcomes and magnetic resonance findings
13. Long-term oncological outcomes after radical prostatectomy and extended pelvic lymph node dissection in high-risk prostate cancer: Comparing last decade to previous 20 years
14. Zero PSA after RP: It is reasonable in selected N+ prostate cancer patients if a ePLND is performed
15. Long-term oncological outcomes after radical prostatectomy and extended pelvic lymph node dissection in high-risk prostate cancer: Comparing last decade to previous 20 years
16. Suburethral male sling: Correlation between continence outcomes and magnetic resonance findings
17. Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer
18. Predictors of transition to watchful waiting from active surveillance among men with low-risk prostate cancer in a Caucasian cohort
19. PT337 - Indication for a single postoperative instillation of chemotherapy in non-muscle-invasive bladder cancer: What factors should be considered?
20. 200 Continence results, acute retention of urine and postoperative urgency after AdVance® male sling surgery: Assessing predictive factors
21. PT005 - Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review
22. PT003 - Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer
23. 1182 - Suburethral male sling: Correlation between continence outcomes and magnetic resonance findings
24. 825 - Zero PSA after RP: It is reasonable in selected N+ prostate cancer patients if a ePLND is performed
25. 820 - Long-term oncological outcomes after radical prostatectomy and extended pelvic lymph node dissection in high-risk prostate cancer: Comparing last decade to previous 20 years
26. 672 - Established stress urinary incontinence after radical prostatectomy: A risk calculator based on the 24-hour pad weight test
27. 208 - Predictors of transition to watchful waiting from active surveillance among men with low-risk prostate cancer in a Caucasian cohort
28. 200 Continence results, acute retention of urine and postoperative urgency after AdVance® male sling surgery: Assessing predictive factors
29. V44 Laparoscopic radical cystectomy with lymphadenectomy guided by indocyanine green
30. V37 Laparoscopic radical prostatectomy in intermediate and high risk prostate cancer. Indocyanine green-guided pelvic lymph node dissection
31. 315 Prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program for early diagnosis of prostate cancer
32. 566 ANAMEM: Prospective and observational study to evaluate cognitive changes in prostate cancer patients undergoing luteinizing hormone-releasing hormone analogue treatment
33. 566 ANAMEM: Prospective and observational study to evaluate cognitive changes in prostate cancer patients undergoing luteinizing hormone-releasing hormone analogue treatment
34. 315 Prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program for early diagnosis of prostate cancer
35. V44 Laparoscopic radical cystectomy with lymphadenectomy guided by indocyanine green
36. V37 Laparoscopic radical prostatectomy in intermediate and high risk prostate cancer. Indocyanine green-guided pelvic lymph node dissection
37. 10 Prospective randomized controlled trial of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening programme for prostate cancer
38. 1007 Intensive preoperatory Pelvic Floor Muscle Training reduce duration and severity of stress urinary incontinence after radical prostatectomy: A randomized controlled trial
39. 343 Optimizing use of PCA3 in initial prostate biopsy: External validation of a proposed nomogram and proposal for a new system to choose cut-off points in nomograms
40. 418 Risk of mestastatic progression depends on time to biochemical failure following radical and clinic-pathologic factors following radical prostatectomy
41. 102 Involvement of TMPRSS2-ERG status and GSTP-1 expression as prognostic biomarkers in the clinical management of prostate cancer
42. 757 The meaning of PSA persistence after radical prostatectomy in low risk prostate cancer
43. 104 Loss of speckle-type POZ protein (SPOP) during prostate cancer progression indicates its role as tumour suppressor gene
44. 343 Optimizing use of PCA3 in initial prostate biopsy: External validation of a proposed nomogram and proposal for a new system to choose cut-off points in nomograms
45. 102 Involvement of TMPRSS2-ERG status and GSTP-1 expression as prognostic biomarkers in the clinical management of prostate cancer
46. 418 Risk of mestastatic progression depends on time to biochemical failure following radical and clinic-pathologic factors following radical prostatectomy
47. 104 Loss of speckle-type POZ protein (SPOP) during prostate cancer progression indicates its role as tumour suppressor gene
48. 757 The meaning of PSA persistence after radical prostatectomy in low risk prostate cancer
49. 1007 Intensive preoperatory Pelvic Floor Muscle Training reduce duration and severity of stress urinary incontinence after radical prostatectomy: A randomized controlled trial
50. 10 Prospective randomized controlled trial of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening programme for prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.